Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway

Published:2019 Issue:25 Volume:10 Page:6439-6456
ISSN:1837-9664
Container-title:Journal of Cancer
language:en
Short-container-title:J. Cancer

Author:

Yuan Li,Zhang Kai,Zhou Meng-Meng,Wasan Harpreet S.,Tao Fang-Fang,Yan Qing-Ying,Feng Guan,Tang Yin-Shan,Shen Min-He,Ma Sheng-Lin,Ruan Shan-Ming

Publisher

Ivyspring International Publisher

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A network pharmacology approach and experimental validation to investigate the anticancer mechanism of Qi-Qin-Hu-Chang formula against colitis-associated colorectal cancer through induction of apoptosis via JNK/p38 MAPK signaling pathway;Journal of Ethnopharmacology;2024-01

2. WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells In Vitro and In Vivo;Current Medicinal Chemistry;2023-09

3. Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer;Frontiers in Oncology;2023-03-13

4. Epigenetic changes induced in mice liver by methionine-supplemented and methionine-deficient diets;Food and Chemical Toxicology;2022-05

5. Traditional Chinese Medicines as Effective Reversals of Epithelial-Mesenchymal Transition Induced-Metastasis of Colorectal Cancer: Molecular Targets and Mechanisms;Frontiers in Pharmacology;2022-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP